Inhibition of EZH2 and activation of ERRγ synergistically suppresses gastric cancer by inhibiting FOXM1 signaling pathway
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of EZH2 and activation of ERRγ synergistically suppresses gastric cancer by inhibiting FOXM1 signaling pathway
Authors
Keywords
-
Journal
Gastric Cancer
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-12
DOI
10.1007/s10120-020-01097-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased Programmed Death-Ligand 1 is an Early Epithelial Cell Response to Helicobacter pylori Infection
- (2019) Loryn Holokai et al. PLoS Pathogens
- Downregulation of tumor suppressor RACK1 by Helicobacter pylori infection promotes gastric carcinogenesis through the integrin β-1/NF-κB signaling pathway
- (2019) Yi Hu et al. CANCER LETTERS
- Combination simvastatin and metformin synergistically inhibits endometrial cancer cell growth
- (2019) Josephine S. Kim et al. GYNECOLOGIC ONCOLOGY
- Advancements and challenges in treating advanced gastric cancer in the West
- (2019) Jennifer L Leiting et al. World Journal of Gastrointestinal Oncology
- Helicobacter pylori pathogen regulates p14ARF tumor suppressor and autophagy in gastric epithelial cells
- (2018) Andela Horvat et al. ONCOGENE
- Estrogen-related receptor gamma functions as a tumor suppressor in gastric cancer
- (2018) Myoung-Hee Kang et al. Nature Communications
- Increased Abundance of Clostridium and Fusobacterium in Gastric Microbiota of Patients with Gastric Cancer in Taiwan
- (2018) Yung-Yu Hsieh et al. Scientific Reports
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Regulation of the master regulator FOXM1 in cancer
- (2018) Guo-Bin Liao et al. Cell Communication and Signaling
- EZH2 contributes to 5-FU resistance in gastric cancer by epigenetically suppressing FBXO32 expression
- (2018) Chenyu Wang et al. OncoTargets and Therapy
- Molecular classification of gastric cancer
- (2017) Christoph Röcken EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Mucosal microbiome dysbiosis in gastric carcinogenesis
- (2017) Olabisi Oluwabukola Coker et al. GUT
- How to stomach an epigenetic insult: the gastric cancer epigenome
- (2017) Nisha Padmanabhan et al. Nature Reviews Gastroenterology & Hepatology
- FoxM1: Repurposing an oncogene as a biomarker
- (2017) Deeptashree Nandi et al. SEMINARS IN CANCER BIOLOGY
- ERRγ: a Junior Orphan with a Senior Role in Metabolism
- (2017) Jagannath Misra et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant
- (2016) Jun Li et al. AMERICAN JOURNAL OF HUMAN GENETICS
- The novel EZH2 inhibitor, GSK126, suppresses cell migration and angiogenesis via down-regulating VEGF-A
- (2016) Ya-Tian Chen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Androgen-Dependent Repression of ERRγ Reprograms Metabolism in Prostate Cancer
- (2016) Étienne Audet-Walsh et al. CANCER RESEARCH
- Targeting EZH2 in cancer
- (2016) Kimberly H Kim et al. NATURE MEDICINE
- Genetic predisposition to gastric cancer
- (2016) Iva Petrovchich et al. SEMINARS IN ONCOLOGY
- Changing strategies for target therapy in gastric cancer
- (2016) Suk-young Lee WORLD JOURNAL OF GASTROENTEROLOGY
- Combination treatment including targeted therapy for advanced hepatocellular carcinoma
- (2016) Jianzhen Lin et al. Oncotarget
- Dual inhibition of survivin and MAOA synergistically impairs growth of PTEN-negative prostate cancer
- (2015) S Xu et al. BRITISH JOURNAL OF CANCER
- Global patterns of cardia and non-cardia gastric cancer incidence in 2012
- (2015) A Colquhoun et al. GUT
- Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germlineCDH1mutation carriers
- (2015) Rachel S van der Post et al. JOURNAL OF MEDICAL GENETICS
- Phase II study of trastuzumab in combination with S-1 plus cisplatin in HER2-positive gastric cancer (HERBIS-1)
- (2014) Y Kurokawa et al. BRITISH JOURNAL OF CANCER
- Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention
- (2014) P. Karimi et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Down-regulation of MicroRNA-494 via Loss of SMAD4 Increases FOXM1 and β-Catenin Signaling in Pancreatic Ductal Adenocarcinoma Cells
- (2014) Lei Li et al. GASTROENTEROLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Gastric Cancer
- (2013) Catherine de Martel et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
- (2013) Tom Waddell et al. LANCET ONCOLOGY
- Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial
- (2013) Florian Lordick et al. LANCET ONCOLOGY
- Transcriptional regulation by Polycomb group proteins
- (2013) Luciano Di Croce et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- FoxM1 Promotes β-Catenin Nuclear Localization and Controls Wnt Target-Gene Expression and Glioma Tumorigenesis
- (2011) Nu Zhang et al. CANCER CELL
- Pertuzumab in Combination with Trastuzumab Shows Significantly Enhanced Antitumor Activity in HER2-Positive Human Gastric Cancer Xenograft Models
- (2011) Y. Yamashita-Kashima et al. CLINICAL CANCER RESEARCH
- Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
- (2011) Atsushi Ohtsu et al. JOURNAL OF CLINICAL ONCOLOGY
- Department of Error
- (2010) LANCET
- Forkhead box M1 transcription factor: A novel target for cancer therapy
- (2009) Zhiwei Wang et al. CANCER TREATMENT REVIEWS
- ERRγ Mediates Tamoxifen Resistance in Novel Models of Invasive Lobular Breast Cancer
- (2008) Rebecca B. Riggins et al. CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started